{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:08:14Z","timestamp":1778760494039,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China Youth Science Foundation Project","award":["82402707"],"award-info":[{"award-number":["82402707"]}]},{"name":"National Natural Science Foundation of China Youth Science Foundation Project","award":["81802571"],"award-info":[{"award-number":["81802571"]}]},{"name":"Zhejiang Medical and Health Science and Technology Project","award":["2019RC039"],"award-info":[{"award-number":["2019RC039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06459-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:16:33Z","timestamp":1778757393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["APOE \u03b52\/\u03b53 is associated with multi-layered protection against prostate cancer in Chinese men"],"prefix":"10.1007","volume":"44","author":[{"given":"Kuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuzhi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xufeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0906-7143","authenticated-orcid":false,"given":"Zhihua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-8057","authenticated-orcid":false,"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"6","key":"6459_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3322\/caac.70020","volume":"75","author":"D Chakrabarti","year":"2025","unstructured":"Chakrabarti D, Albertsen P, Adkins A et al (2025) The contemporary management of prostate cancer. CA Cancer J Clin 75(6):552\u2013586. https:\/\/doi.org\/10.3322\/caac.70020","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"6459_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB (2025) Prostate Cancer: A Review. JAMA 333(16):1433\u20131446. https:\/\/doi.org\/10.1001\/jama.2025.0228","journal-title":"JAMA"},{"issue":"4","key":"6459_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10555-024-10193-8","volume":"43","author":"JB Kaushal","year":"2024","unstructured":"Kaushal JB, Raut P, Muniyan S et al (2024) Racial disparity in prostate cancer: an outlook in genetic and molecular landscape. Cancer Metastasis Rev 43(4):1233\u20131255. https:\/\/doi.org\/10.1007\/s10555-024-10193-8","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"6459_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol 77(1):38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005","journal-title":"Eur Urol"},{"issue":"8","key":"6459_CR5","doi-asserted-by":"publisher","first-page":"e2412244","DOI":"10.1002\/advs.202412244","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Yu X, Yang G et al (2025) Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer. Adv Sci (Weinh) 12(8):e2412244. https:\/\/doi.org\/10.1002\/advs.202412244","journal-title":"Adv Sci (Weinh)"},{"key":"6459_CR6","doi-asserted-by":"publisher","first-page":"117365","DOI":"10.1016\/j.bios.2025.117365","volume":"278","author":"G Lin","year":"2025","unstructured":"Lin G, Liang W, He Q, Wang Y, Yang X (2025) Dual single nucleotide polymorphisms typing of apolipoprotein E gene based on double restriction endonuclease with lambda exonuclease and triple helix molecular switch assistance. Biosens Bioelectron 278:117365. https:\/\/doi.org\/10.1016\/j.bios.2025.117365","journal-title":"Biosens Bioelectron"},{"issue":"4","key":"6459_CR7","first-page":"779","volume":"22","author":"MC Venanzoni","year":"2003","unstructured":"Venanzoni MC, Giunta S, Muraro GB et al (2003) Apolipoprotein E expression in localized prostate cancers. Int J Oncol 22(4):779\u2013786","journal-title":"Int J Oncol"},{"issue":"11","key":"6459_CR8","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/alz.12538","volume":"18","author":"T Wang","year":"2022","unstructured":"Wang T, Huynh K, Giles C et al (2022) APOE epsilon2 resilience for Alzheimer\u2019s disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimers Dement 18(11):2151\u20132166. https:\/\/doi.org\/10.1002\/alz.12538","journal-title":"Alzheimers Dement"},{"key":"6459_CR9","doi-asserted-by":"publisher","first-page":"1051280","DOI":"10.3389\/fphar.2022.1051280","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, Chen J, Ma Y, Chen H (2022) Apolipoproteins: New players in cancers. Front Pharmacol 13:1051280. https:\/\/doi.org\/10.3389\/fphar.2022.1051280","journal-title":"Front Pharmacol"},{"issue":"10","key":"6459_CR10","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1158\/1055-9965.EPI-15-0367","volume":"24","author":"H Liu","year":"2015","unstructured":"Liu H, Shui IM, Platz EA, Mucci LA, Giovannucci EL (2015) No Association of ApoE Genotype with Risk of Prostate Cancer: A Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev 24(10):1632\u20131634. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0367","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"6459_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.21147\/j.issn.1000-9604.2022.03.07","volume":"34","author":"Health Commission Of The People\u2019s Republic Of China N","year":"2022","unstructured":"Health Commission Of The People\u2019s Republic Of China N (2022) National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version). Chin J Cancer Res 34(3):270\u2013288. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2022.03.07","journal-title":"Chin J Cancer Res"},{"issue":"D1","key":"6459_CR12","doi-asserted-by":"publisher","first-page":"D1186","DOI":"10.1093\/nar\/gkaa1005","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tian D, Tang B, Liu X, Teng X, Zhao W et al (2021) Genome Variation Map: a worldwide collection of genome variations across multiple species. Nucleic Acids Res 49(D1):D1186\u2013D1191. https:\/\/doi.org\/10.1093\/nar\/gkaa1005","journal-title":"Nucleic Acids Res"},{"key":"6459_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1078","author":"C-N Members","year":"2024","unstructured":"Members C-N, Partners (2024) Nucleic Acids Res 52(D1):D18\u2013D32. https:\/\/doi.org\/10.1093\/nar\/gkad1078. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2024"},{"issue":"1","key":"6459_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13244-024-01699-4","volume":"15","author":"E Guo","year":"2024","unstructured":"Guo E, Xu L, Zhang D, Zhang J, Zhang X, Bai X et al (2024) Diagnostic performance of MRI in detecting prostate cancer in patients with prostate-specific antigen levels of 4\u201310 ng\/mL: a systematic review and meta-analysis. Insights Imaging 15(1):147. https:\/\/doi.org\/10.1186\/s13244-024-01699-4","journal-title":"Insights Imaging"},{"key":"6459_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.10177","author":"R Voelker","year":"2025","unstructured":"Voelker R (2025) What Is Prostate Cancer? JAMA. https:\/\/doi.org\/10.1001\/jama.2025.10177","journal-title":"JAMA"},{"issue":"3","key":"6459_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/bju.15533","volume":"129","author":"J Bjorklund","year":"2022","unstructured":"Bjorklund J, Stattin P, Ronmark E, Aly M, Akre O (2022) The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study. BJU Int 129(3):318\u2013324. https:\/\/doi.org\/10.1111\/bju.15533","journal-title":"BJU Int"},{"issue":"1","key":"6459_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12916-021-02230-y","volume":"20","author":"SWD Merriel","year":"2022","unstructured":"Merriel SWD, Pocock L, Gilbert E et al (2022) Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med 20(1):54. https:\/\/doi.org\/10.1186\/s12916-021-02230-y","journal-title":"BMC Med"},{"issue":"3","key":"6459_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5551\/jat.65393","volume":"32","author":"A Matsunaga","year":"2025","unstructured":"Matsunaga A, Saito T (2025) Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features. J Atheroscler Thromb 32(3):281\u2013303. https:\/\/doi.org\/10.5551\/jat.65393","journal-title":"J Atheroscler Thromb"},{"issue":"10","key":"6459_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/jnci\/djaa001","volume":"112","author":"EAM Heijnsdijk","year":"2020","unstructured":"Heijnsdijk EAM, Gulati R, Tsodikov A et al (2020) Lifetime Benefits and Harms of Prostate-Specific Antigen-Based Risk-Stratified Screening for Prostate Cancer. J Natl Cancer Inst 112(10):1013\u20131020. https:\/\/doi.org\/10.1093\/jnci\/djaa001","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"6459_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jech.54.12.938","volume":"54","author":"M Niemi","year":"2000","unstructured":"Niemi M, Kervinen K, Kiviniemi H et al (2000) Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health 54(12):938\u2013939. https:\/\/doi.org\/10.1136\/jech.54.12.938","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"6459_CR21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3892\/ijo.2013.2057","volume":"43","author":"GO Ifere","year":"2013","unstructured":"Ifere GO, Desmond R, Demark-Wahnefried W, Nagy TR (2013) Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis. Int J Oncol 43(4):1002\u20131010. https:\/\/doi.org\/10.3892\/ijo.2013.2057","journal-title":"Int J Oncol"},{"issue":"2","key":"6459_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41391-021-00398-1","volume":"25","author":"CR Buskbjerg","year":"2022","unstructured":"Buskbjerg CR, Amidi A, Buus S, Gravholt CH, Hadi Hosseini SM, Zachariae R (2022) Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes. Prostate Cancer Prostatic Dis 25(2):208\u2013218. https:\/\/doi.org\/10.1038\/s41391-021-00398-1","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6459_CR23","doi-asserted-by":"publisher","unstructured":"Perks CM, Barker RM, Alhadrami M et al (2025) Curious Dichotomies of Apolipoprotein E Function in Alzheimer\u2019s Disease and Cancer-One Explanatory Mechanism of Inverse Disease Associations? Genes (Basel) 16(3). https:\/\/doi.org\/10.3390\/genes16030331","DOI":"10.3390\/genes16030331"},{"issue":"2","key":"6459_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.pcan.4500405","volume":"3","author":"K Haapala","year":"2000","unstructured":"Haapala K, Lehtimaki T, Ilveskoski E, Koivisto PA, Haapala K (2000) Apolipoprotein E genotype is not linked to locally recurrent hormone-refractory prostate cancer. Prostate Cancer Prostatic Dis 3(2):107\u2013109. https:\/\/doi.org\/10.1038\/sj.pcan.4500405","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6459_CR25","doi-asserted-by":"publisher","unstructured":"Hysi PG, Mangino M, Christofidou P et al (2022) Metabolome Genome-Wide Association Study Identifies 74 Novel Genomic Regions Influencing Plasma Metabolites Levels. Metabolites 12(1). https:\/\/doi.org\/10.3390\/metabo12010061","DOI":"10.3390\/metabo12010061"},{"key":"6459_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12944-015-0025-2","volume":"14","author":"YP Sun","year":"2015","unstructured":"Sun YP, Zhang B, Miao L et al (2015) Association of apolipoprotein E (ApoE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China. Lipids Health Dis 14:25. https:\/\/doi.org\/10.1186\/s12944-015-0025-2","journal-title":"Lipids Health Dis"},{"issue":"12","key":"6459_CR27","doi-asserted-by":"publisher","first-page":"12222","DOI":"10.18632\/aging.103405","volume":"12","author":"CL Kuo","year":"2020","unstructured":"Kuo CL, Pilling LC, Atkins JL, Kuchel GA, Melzer D (2020) ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants. Aging 12(12):12222\u201312233. https:\/\/doi.org\/10.18632\/aging.103405","journal-title":"Aging"},{"issue":"1","key":"6459_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/gerona\/gly174","volume":"74","author":"P Sebastiani","year":"2019","unstructured":"Sebastiani P, Gurinovich A, Nygaard M et al (2019) APOE Alleles and Extreme Human Longevity. J Gerontol Biol Sci Med Sci 74(1):44\u201351. https:\/\/doi.org\/10.1093\/gerona\/gly174","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"1","key":"6459_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11357-022-00646-9","volume":"45","author":"P Sebastiani","year":"2023","unstructured":"Sebastiani P, Song Z, Ellis D et al (2023) A metabolomic signature of the APOE2 allele. Geroscience 45(1):415\u2013426. https:\/\/doi.org\/10.1007\/s11357-022-00646-9","journal-title":"Geroscience"},{"issue":"10","key":"6459_CR30","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","volume":"74","author":"SC Neu","year":"2017","unstructured":"Neu SC, Pa J, Kukull W et al (2017) Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurol 74(10):1178\u20131189. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2188","journal-title":"JAMA Neurol"},{"issue":"4","key":"6459_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCRESAHA.123.323921","volume":"134","author":"R Toribio-Fernandez","year":"2024","unstructured":"Toribio-Fernandez R, Tristao-Pereira C, Carlos Silla-Castro J et al (2024) Apolipoprotein E-epsilon2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study. Circ Res 134(4):411\u2013424. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323921","journal-title":"Circ Res"},{"issue":"1","key":"6459_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaophthalmol.2022.4602","volume":"141","author":"KL Rasmussen","year":"2023","unstructured":"Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R (2023) Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration. JAMA Ophthalmol 141(1):13\u201321. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4602","journal-title":"JAMA Ophthalmol"},{"key":"6459_CR33","doi-asserted-by":"publisher","first-page":"114127","DOI":"10.1016\/j.biopha.2022.114127","volume":"158","author":"G Miao","year":"2023","unstructured":"Miao G, Zhuo D, Han X et al (2023) From degenerative disease to malignant tumors: Insight to the function of ApoE. Biomed Pharmacother 158:114127. https:\/\/doi.org\/10.1016\/j.biopha.2022.114127","journal-title":"Biomed Pharmacother"},{"key":"6459_CR34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","volume":"151","author":"N Pencheva","year":"2012","unstructured":"Pencheva N, Tran H, Buss C et al (2012) Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151:1068\u20131082. https:\/\/doi.org\/10.1016\/j.cell.2012.10.028","journal-title":"Cell"},{"key":"6459_CR35","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.jlr.2024.100498","volume":"65","author":"FC Almeida","year":"2024","unstructured":"Almeida FC, Patra K, Giannisis A et al (2024) APOE genotype dictates lipidomic signatures in primary human hepatocytes. J Lipid Res 65:100498. https:\/\/doi.org\/10.1016\/j.jlr.2024.100498","journal-title":"J Lipid Res"},{"key":"6459_CR36","doi-asserted-by":"publisher","first-page":"120568","DOI":"10.1016\/j.atherosclerosis.2025.120568","volume":"411","author":"YA Barakji","year":"2025","unstructured":"Barakji YA, Hupfeld NB, Bertelsen CA et al (2025) Common genetic variation in the APOE gene and risk of cancer: a systematic review and meta-analysis. Atherosclerosis 411:120568. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120568","journal-title":"Atherosclerosis"},{"key":"6459_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12944-025-02842-w","volume":"25","author":"B Zeng","year":"2025","unstructured":"Zeng B, Ma C, Zhang S et al (2025) The association between APOE allele variants and inflammatory markers in a large-scale Chinese population. Lipids Health Dis 25:28. https:\/\/doi.org\/10.1186\/s12944-025-02842-w","journal-title":"Lipids Health Dis"},{"key":"6459_CR38","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/0008-5472.CAN-21-1807","volume":"82","author":"F Ma","year":"2022","unstructured":"Ma F, Arai S, Wang K et al (2022) Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer. Cancer Res 82:1518\u20131533. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1807","journal-title":"Cancer Res"},{"issue":"2","key":"6459_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/biom12020309","volume":"12","author":"S Koushyar","year":"2022","unstructured":"Koushyar S, Meniel VS, Phesse TJ, Pearson HB (2022) Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer. Biomolecules 12(2):309. https:\/\/doi.org\/10.3390\/biom12020309","journal-title":"Biomolecules"},{"issue":"8","key":"6459_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/pharmaceutics13081195","volume":"13","author":"NM Roudsari","year":"2021","unstructured":"Roudsari NM, Lashgari NA, Momtaz S et al (2021) Inhibitors of the PI3K\/Akt\/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics 13(8):1195. https:\/\/doi.org\/10.3390\/pharmaceutics13081195","journal-title":"Pharmaceutics"},{"key":"6459_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2741\/4443","volume":"21","author":"H Chen","year":"2016","unstructured":"Chen H, Zhou L, Wu X et al (2016) The PI3K\/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed) 21:1084\u20131091. https:\/\/doi.org\/10.2741\/4443","journal-title":"Front Biosci (Landmark Ed)"},{"key":"6459_CR42","doi-asserted-by":"publisher","first-page":"103495","DOI":"10.1016\/j.critrevonc.2021.103495","volume":"167","author":"O Oey","year":"2021","unstructured":"Oey O, Ghaffari M, Li JJ, Hosseini-Beheshti E (2021) Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice. Crit Rev Oncol Hematol 167:103495. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103495","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06459-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06459-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06459-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:16:34Z","timestamp":1778757394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06459-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6459"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06459-1","relation":{"references":[{"id-type":"doi","id":"10.1093\/nar\/gkad1078","asserted-by":"subject"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All related procedures were performed with the approval of the internal review and ethics boards of The Second Affiliated Hospital, Zhejiang University School of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"361"}}